N
Northwell Health | South Shore University Hospital - Clinical Research Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Apixaban
Dofetilide
Coumadin
Flecainide
Propafenone
Sotalol
Rivaroxaban
Parent organization
This site is a part of Northwell Health
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
The primary objective of this study is to determine if left atrial appendage closure with the WATCHMAN FLX Device is a reasonable alternative to oral...
Active, not recruiting
Atrial Fibrillation
Device: WATCHMAN FLX Implant
Drug: Market-approved OAC
This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maint...
Enrolling
Venous Thromboembolism
Deep Venous Thrombosis
Device: ClotTriever System
Drug: Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...
Enrolling
Persistent Atrial Fibrillation
Device: FARAPULSE™ Pulsed Field Ablation (PFA) System
Drug: Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, and Dofetilide
Trial sponsors
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems